Method for diagnosing remyelinating processes and corrective processes of myelin sheath in patients with diagnosed disseminated sclerosis

摘要

the subject of this application is the way active detection, remielinizuju0105cych lezji patients suffering from multiple sclerosis by determination of changes in the level of interleukin - 33 in peripheral blood and csf, which is a new marker of endogenous procesu00f3 in the corrective, allowing monitoring of differentiation, progenitor cells oligodendrocytu00f3w patients.the declaration also includes application of interleukin - 33 to monitor differentiation, progenitor cells oligodendrocytu00f3w in patients diagnosed with multiple sclerosis.